Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

116.14 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 116.14
Bid (Size) 116.00 (1)
Ask (Size) 117.96 (1)
Prev. Close 116.14
Today's Range 116.14 - 116.14
52wk Range 74.80 - 121.83
Shares Outstanding 1,253,809,440
Dividend Yield 2.72%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy
Kite Pharma is acquiring Interius BioTherapeutics for $350 million, adding in vivo CAR T technology that could simplify treatment and expand patient access. 
Via Benzinga
Why Gilead Sciences (GILD) Shares Are Sliding Today
Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) fell 3.5% in the morning session after reports that CVS Health will not be adding the company's new HIV prevention drug, Yeztugo, to... 
Via StockStory
Topics Earnings

Performance

YTD
+26.4%
+26.4%
1 Month
+5.4%
+5.4%
3 Month
+8.8%
+8.8%
6 Month
+5.6%
+5.6%
1 Year
+54.6%
+54.6%

More News

Read More
These S&P500 stocks are gapping in today's session
Via Chartmill
Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug
Via Investor's Business Daily
CVS Health Reportedly Keeps Gilead’s New HIV Preventative Shot Off Its Plans, Faces $290M Medicare Fraud Ruling
Via Stocktwits
Topics Fraud
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans
Via Benzinga
Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences to Present at Upcoming Investor Conferences
From Gilead Sciences, Inc.
Via Business Wire
Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies
Via Benzinga
GILEAD SCIENCES INC (NASDAQ:GILD) Presents a Compelling Case for Value Investors
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
NAFA Publishes New Fleet Safety Guidebook Aimed at Developing Safety-First Culture in all Organizations
Via News Direct
Xilio Revenue Jumps 246 Percent in Q2
Via The Motley Fool
Topics Intellectual Property
Gilead Sciences’s Q2 Earnings Call: Our Top 5 Analyst Questions
Via StockStory
Topics Earnings
Q2 Rundown: Gilead Sciences (NASDAQ:GILD) Vs Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
Is Gilead Sciences Gaining or Losing Market Support?
Via Benzinga
GILD Q2 Deep Dive: HIV Franchise Drives Growth, New Launches and Pipeline in Focus
Via StockStory
Kymera Revenue Drops 55 Percent in Q2
Via The Motley Fool
Topics Intellectual Property
Market Monitor News August 11 BMO - Nasdaq Breaks Records, But The Trade Desk Hits a Wall
Via Chartmill
Gilead Sciences Shares Soar; Analysts Lift Targets On HIV Strength And Yeztugo Outlook
Via Talk Markets
Wall Street's Resilient Rally: What's Driving the Positive Momentum
Via MarketMinute
Topics Artificial Intelligence Economy Electric Vehicles
Earnings Season Boosts Confidence: Gilead and Expedia Lead Strong Corporate Results
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Top S&P500 movers in Friday's session
Via Chartmill
Tech Stocks Eye Record Highs As Magnificent Seven Top $19.5 Trillion: What's Moving Markets Friday?
Via Benzinga
Earnings Season Highlights: Gilead Sciences and Expedia Group Post Strong Results
Via MarketMinute
Topics Artificial Intelligence Earnings Economy

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 116.14
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 08/21/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 145.62B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 146B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.